AGP Executive Report
Last update: 5 hours agoCBD Regulation: Michigan hemp advocates say Congress’s 30-day delay does little to ease uncertainty ahead of a Dec. 11 federal deadline that could remove many hemp-derived THC products and some CBD products from the market; they favor an age-21 sales rule. CBD Products: MediPharm Labs has shipped its first CBD metered-dose inhaler to Panama, expanding its medical-cannabis reach. Global Supply: Tilray Medical won approval to bring EU-GMP quality testing in-house, aiming to speed releases across regulated markets. Medical Cannabis Investment: Brazil’s Ease Labs plans R$100 million in investment over three years as it pursues exports of cannabis medicines and ingredients and considers expanding cultivation into Brazil. Clinical Research: A federally funded study reports that medical marijuana improved cancer-related symptoms and helped reduce opioid use.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.